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Abstract
Background: Expansion of a CAG repeat in the coding region of exon 1 in the ATXN2 gene located in human chromosome
12q24.1 causes the neurodegenerative disease spinocerebellar ataxia type 2 (SCA2). In contrast to other polyglutamine
(polyQ) disorders, the SCA2 repeat is not highly polymorphic in central European (CEU) controls with Q22 representing 90%
of alleles, and Q23 contributing between 5–7% of alleles. Recently, the ATXN2 CAG repeat has been identified as a target of
adaptive selection in the CEU population. Mouse lines deficient for atxn2 develop marked hyperphagia and obesity raising
the possibility that loss-of-function mutations in the ATXN2 gene may be related to energy balance in humans. Some
linkage studies of obesity related phenotypes such as antipsychotic induced weight gain have reported significant lod
scores on chromosome 12q24. We tested the hypothesis that rare loss-of-function ATXN2 variants cause obesity analogous
to rare mutations in the leptin, leptin receptor and MC4R genes.
Methodology/Principal Findings: We sequenced the coding region of ATXN2 including intron-exon boundaries in 92
severely obese children with a body mass index (BMI) .3.2 standard deviations above age- and gender-adjusted means. We
confirmed five previously identified single nucleotide polymorphisms (SNPs) and three new SNPs resulting in two
synonymous substitutions and one intronic polymorphism. Alleles encoding .Q22 were overrepresented in our sample of
obese children and contributed 15% of alleles in children identified by their parents as white. SNP rs695872 closely flanking
the CAG repeat showed a greatly increased frequency of C/C homozygotes and G/C heterozygotes compared with reported
frequencies in the CEU population.
Conclusions/Significance: Although we did not identify variants leading to novel amino acid substitutions, nonsense or
frameshift mutations, this study warrants further examination of variation in the ATXN2 gene in obesity and related
phenotypes in a larger case-control study with emphasis on rs695872 and CAG repeat structure.
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Introduction
The ataxin-2 protein is a 1312 amino acid protein of unknown
function encoded by 25 coding exons of the SCA2/ATXN2 gene
[1,2]. The protein contains a polyglutamine domain, which is
encoded by a CAG/CAA repeat in exon 1 of the gene. Expansion of
the CAG repeat and the consequent elongation of the polyQ domain
to $32 repeats causes the neurodegenerative disease spinocerebellar
ataxia type 2 (SCA2). ATXN2 is widely expressed in neuronal and
non-neuronal tissues and is highly conserved in the mouse at the
nucleotide and amino acid level [3,4]. The region containing the
ATXN2 gene on 12q24.1 has undergone significant selection in
Central Europeans (CEU) [5]. The selected allele is associated with a
specific twice CAG repeat that is interrupted twice by a CAA codon.
The function of ATXN2 has remained largely unknown. It is a
cytoplasmic protein with Golgi association [6] which may play a
role in RNA splicing via its interaction with A2BP1/FOX-1 [7,8].
An association with polyribosomes has been observed in the fly
[9]. Ralser and colleagues identified interactions between ataxin-2
and endophilin proteins in plastin-associated cellular pathways
[10]. ATXN2 also interacts with the DEAD/H-box RNA helicase
DDX6, components of P-bodies and stress granules[11].
ATXN2 deficiency in the rodent did not result in a neurode-
generative phenotype, but led to marked obesity [12]. These
results have recently found independent confirmation [13].
Genetic linkage studies of human obesity-related traits have also
implicated the ATXN2 region on human chromosome 12q24. Li
and coworkers identified linkage for body mass index (BMI) and
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to the ATXN2 gene[14]. This region has also been implicated in
studies of obesity associated with antipsychotic medication.
Highest lod scores were obtained with the marker D12S79, which
is 4MB telomeric of ATXN2[15]. Parent-of-origin analysis of
obesity traits implicated the region around D12S2070 as well with
higher lod scores obtained for maternal transmissions [16]. Other
groups, however, identified linkage signals further distal to the
ATXN2 locus in 12q24.3 [17,18]. To elucidate a potential role for
ATXN2 in human obesity we examined the coding region of
ATXN2 in 92 patients with severe obesity of early onset recruited
to the UK Genetics of Obesity Study.
Results
Based on our finding of hyperphagia and obesity in mice
hemizygously or homozygously deficient for ATXN2 we tested
the hypothesis that loss-of-function mutations in ATXN2 are
responsible for a subset of human obesity. We sequenced the 25
coding exons of the human ATXN2 gene in 92 severely obese
children enrolled in the Genetics of Obesity Study (GOOS) with
a mean body mass index .3.2 standard deviations above the
mean. Using primers located in the introns flanking the
respective exon (Table S1) we searched for coding sequence
variation as well as for variants leading to an alteration in
splicing.
Table 1 lists the location and nature of eight DNA sequence
variants separately for our entire cohort (n=92) and those children
with two self-identified white parents (n=77) as well as SNP
frequencies reported in the Hap-Map CEU population (n=55).
Overall, no variants were detected that changed the amino acid
sequence of ataxin-2 other than one previously reported single
nucleotide polymorphism (SNP). This SNP (rs695871) had the
same genotype frequencies as reported for the CEU reference
population (Table 1). We also identified two rare synonymous
changes in exons 1 and 23 that had not previously been reported.
These basepair changes are likely rare normal variants and are not
expected to induce cryptic splice sites.
Two additional SNPs had been previously reported in
European and Asian populations; rs695872 is located in exon 1
just upstream of the CAG repeat and results in a synonymous
change, rs2073950 is located in intron 22. For both SNPs,
genotype frequencies in the samples of obese white children from
the U.K. were significantly different from those reported in the
Hap-Map CEU sample (Table 1; rs695872, chi-square 36, DF 2,
nominal p,0.0000001; rs2073950, chi-square 10.2, DF 2,
nominal p,0.007). Both SNPs have significantly different allele
frequencies in white and Asian populations.
Table 1. ATXN2 Sequence Variants found in the Genetics of Obesity Study (GOOS) Cohort.
Location SNP ID Type Flanking Sequence
Sequence
Variation Site
Amino acid
change
Genotype
Frequency
Total cohort
Genotype
Frequency
White Only
Frequency
Hap-Map-CEU
Exon 1 Coding GCCCGGG/CTGGCGC c.81G.C p.= C/C=0.00 C/C=0.00 NA
C/G=0.02 C/G=0.02
G/G=0.98 G/G=0.98
Exon 1 rs695871 Coding GTCGTCC/GTCCTTC c.319C.G p.Leu107Val C/C=0.07 C/C=0.08 C/C=0.07
C/G=0.35 C/G=0.32 C/G=0.42
G/G=0.58 G/G=0.60 G/G=0.51
Exon 1 rs695872** Coding CGCCCGC/TGCGTCC c.390C.T p.= C/C=0.08* C/C=0.08 C/C=0.00
C/T=0.36* C/T=0.34 C/T=0.06
T/T=0.57* T/T=0.58 T/T=0.94
Intron 15 Non-Coding TAGACCA/CTCCTGT c.2882+24C.A C/C=0.96 C/C=0.96 NA
C/A=0.04 C/A=0.04
A/A= 0.00 A/A= 0.00
Intron 21 rs12301585 Non-coding TGGAGGT/GTGTCAG c.3371-46T.G G/G=0.00 G/G=0.00 G/G=0.00
G/T=0.02 G/T=0.00 G/T=0.00
T/T=0.98 T/T=1.00 T/T=1.00
Intron 21 rs2301622 Non-coding TTGTCAG/CACATCG c.3371-40G.C C/C=0.08 C/C=0.07 C/C=0.03
C/G=0.40 C/G=0.39 C/G= 0.41
G/G=0.52 G/G=0.54 G/G=0.55
Intron 22 rs2073950 Non-coding TTTCCTG/ATCGCTT c.3517-12G.A A/A=0.03 A/A=0.04 A/A=0.03
A/G=0.21* A/G=0.21 A/G=0.42
G/G=0.76* G/G=0.75 G/G=0.55
Exon 23 Coding GCCGGCG/ATATACC c.3744G.A p.= A/A=0.00 A/A=0.00 NA
A/G=0.04 A/G=0.05
G/G=0.96 G/G=0.95
RefSeq NM_002973.3.
*The genotype frequencies are statistically different than those reported for the Hap-Map CEU population.
**Frequencies for Hap-Map CEU not available for this SNP, CEPH frequencies given.
doi:10.1371/journal.pone.0008280.t001
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repeat as the CAG repeat is known to be interrupted by CAA
codons. This repeat is relatively invariant in the CEU population,
but highly variable in Africans. The most common allele
worldwide has 22 repeats with a composition of (CAG)8CAA
(CAG)4CAA(CAG)8 and has undergone adaptive selection in
the CEU population [5]. We confirmed the known repeat con-
figurations in our sample and detected a total of 15 different
CAG/CAA repeat alleles (Table 2, Table S2). Five of the
alleles (CAG)10CAA(CAG)11; (CAG)8CAA(CAG)5CAA(CAG)7;
(CAG)25; (CAG)13CAA(CAG)11; (CAG)13CAACAG13) had not
been previously identified in over 900 alleles worldwide. Overall,
we detected a higher frequency of alleles with 23 or more repeats
in our white cohort (14.9%) than reported for the CEU (9.1%,
n=110) or the Polish (7.7%, n=234) populations. Given the large
numbers of comparisons necessary, we did not attempt a statistical
analysis of CAG repeat allele frequencies and repeat alleles. A
larger number of obese individuals need to be examined to
determine whether particular repeat alleles are associated with the
development of obesity.
Discussion
The ATXN2 gene was initially identified as the gene mutated in
SCA2, a human neurodegenerative disease. The only mutations
identified so far consist of expansion of a CAG repeat in exon 1,
which encodes a polyglutamine domain leading to aggregation of
the protein in neurons [3,19,20]. Knock-out of the ATXN2 gene in
the mouse resulted in marked obesity with onset shortly after
weaning [12,13]. Weight gain occurred as a result of increased
food intake. This phenotype was also observed in heterozygote
animals. Hyperphagia and weight gain were intermediate between
wildtype and homozygote knockouts pointing to subtle effects of
gene dosage (Pulst SM, unpublished).
Other types of mutations have not been described in humans
and few coding variants have been deposited into genomic
databases. The rationale for the present study was provided by the
finding of obesity in Atxn2 knockout mice [12] and the presence of
linkage signals for obesity-related traits on 12q24, the location of
the human ATXN2 gene [14,15,16]. We hypothesized that we
would detect rare loss-of-function genetic variants similar to the
link between obesity and rare variants in the leptin, leptin receptor
and MC4R genes [21].
We sequenced the 25 coding exons and intron-exon boundaries
of ATXN2 in children with severe obesity. Our results did not
support a major role of ATXN2 coding variants in the causation of
human childhood obesity. The paucity of coding variants in this
relatively large gene was surprising as we did not identify any
amino acid substitutions other than the known p.Leu107Val
(rs695871) polymorphism. Nonsense mutations, or changes near
exon-intron boundaries were absent in the 92 samples, One
synonymous coding SNP (rs695872), and one intronic SNP
(rs2073950) showed nominally significant deviations from geno-
type frequencies reported for the CEU population sample. Our
study was not designed as a case-control allelic association study
and these observations need to be repeated in an ethnically
matched sample of obese and lean children.
Recent studies suggested that evolutionary selection acted upon
the ATXN2 CAG repeat or closely linked SNPs[5]. An allele with
the (CAG)8CAA(CAG)4CAA(CAG)8 configuration appears to
have been selected in Northern Europeans. Although CAA
interruptions do not change the amino acid sequence, they lead
to branched structures at the DNA and RNA level in vitro [22]. We
therefore analyzed not only the repeat length, but also the
Table 2. Allele Frequency in the GOOS Cohort and 9 other Populations.
Repeat Structure
Repeat
size
Mixed
Pop
n=184
a
White
Only*
n=154
a
CEU
n=110
b
French
n=17
c
Spanish
n=11
d
Polish
n234
e
Indian
n=215
f
CHB
n=86
b
JPT
n=129
b, g, h
YRI
n=106
b
(CAG)12CAA(CAG)8 21 0.006 (1) 0.004 (1) 0.005 (1)
(CAG)8CAA(CAG)4CAA(CAG)7 21 0.005 (1) 0.006 (1) 0.023 (3)
(CAG)22 22 0.009 (1)
(CAG)8CAA(CAG)13 22 0.005 (1) 0.006 (1) 0.009 (1)
(CAG)10CAA(CAG)11 22 0.005 (1) 0.006 (1)
(CAG)13CAA(CAG)8 22 0.14 (26) 0.136 (21) 0.173 (19) 0.118 (2) 0.145 (34) 0.205 (44) 0.442 (38) 0.217 (28) 0.132 (14)
(CAG)8CAA(CAG)4CAA(CAG)8 22 0.696 (128) 0.688 (106) 0.727 (80) 0.529 (9) 0.455 (5) 0.765 (179) 0.707 (152) 0.558 (48) 0.744 (96) 0.358 (38)
(CAG)8CAA(CAG)5CAA(CAG)7 22 0.005 (1)
(CAG)9CAA(CAG)4CAA(CAG)8 23 0.005 (1) 0.006 (1) 0.004 (1) 0.005 (1)
(CAG)13CAA(CAG)9 23 0.043 (8) 0.052 (8) 0.009 (1) 0.021 (5) 0.014 (3)
(CAG)14CAA(CAG)8 23 0.049 (9) 0.058 (9) 0.064 (7) 0.030 (7) 0.014 (3)
(CAG)8CAA(CAG)14 23 0.005 (1) 0.006 (1) 0.059 (1) 0.028 (3)
(CAG)8CAA(CAG)5CAA(CAG)8 23 0.016 (3) 0.059 (1) 0.377 (40)
(CAG)25 25 0.011 (2) 0.013 (2)
(CAG)13CAA(CAG)11 25 0.005 (1) 0.006 (1)
(CAG)13CAA(CAG)13 27 0.005 (1) 0.006 (1)
NA** $27 0.018 (2) 0.118 (2) 0.090 (2) 0.017 (4) 0.023 (5) 0.009 (1)
aPulst et al (2009),
b Gibbs et al (2005),
c Imbert et al (1996),
d Pujana et al (1999),
e Krzyzosiak et al (2004),
f Choudhry et al,
g Mizuhima et al (1999),
h Sanpei et al (1996).
*This number is contained within the n=184 of the Mixed population.
**Repeats $27 CAG repeats not found within our cohort.
doi:10.1371/journal.pone.0008280.t002
Obesity and SCA2
PLoS ONE | www.plosone.org 3 December 2009 | Volume 4 | Issue 12 | e8280structure of the repeat with respect to the location and number of
CAA interruptions (Table 2, Table 2S). As reported for virtually all
populations, the allele with 22 repeats and two CAA interruptions
made up the vast majority of alleles. We did not find unusually
expanded repeat lengths in the obese children, but 5 repeat
structures that had not been previously seen in over 900 alleles
worldwide. Four of these had $23 repeats. Overall repeats $23
were more common in white obese children than previously
reported for CEU and Polish populations. It is important to note
that an effect of the ATXN2 repeat structure on obesity-related
traits would be difficult to detect using adjacent SNPs in genome-
wide association studies due to the higher mutation frequency of
trinucleotide repeats in human populations.
Several limitations of our study need to be recognized. A sample
size of 92 severely obese children may not be sufficient to detect
rare variants. Our sequencing strategy would not have detected
the presence of larger insertions/deletions and did not examine
regions that likely control expression of the ATXN2 gene. There
are large evolutionarily conserved regions both upstream of the
coding region, but also in intron 1 of the ATXN2 gene. These
regions deserve further study before variants in the ATXN2 gene
can be excluded from contributing to variation in human body
weight or related phenotypes. Furthermore, ATXN2 gene variants
could be important for other obesity-related phenotypes such as
later-onset obesity or obesity associated with developmental delay.
This study, however, provides a framework for the interpretation
of future coding sequence variants and the possibility for
understanding adaptive selection biases acting upon the ATXN2
repeat structure or flanking regions.
Materials and Methods
Cohort
The Genetics of Obesity Study (GOOS) is a large cohort of
patients with severe early onset obesity [23]. Inclusion criteria for
the GOOS cohort are severe obesity defined as a BMI standard
deviation score (S.D.S) .3.2, and onset of obesity before 10 years
of age. Ninety-two patients in whom the known monogenic causes
of obesity had been excluded by sequencing of the genes encoding
LEP, LEPR, POMC and MC4R were selected for this study. 77
patients in this study were U.K. white, 6 were Indonesian, 2 Afro-
Caribbean and the remainder 7 of mixed background. Mean BMI
was .3.2 standard deviations above the mean (corrected for age
and gender), age of onset of obesity was 4 years.
Ethics Statement
All subjects gave their written informed consent and the study
was approved by the Cambridge Local Regional Ethics Commit-
tee, U.K. The study was conducted according to the principles of
the Helsinki Declaration.
Sequence Analysis
PCR reactions were done under the following conditions: 50 ng
(5 mL) of genomic DNA, 80 ng of each primer (Table S1), 10 mM
dNTP mix (Roche), 1X (2 mL) of 10X Buffer (Qiagen), 1 unit
(0.2 mL) of Hot Taq (Qiagen), 2 mL of Q solution (Qiagen) and
ddH20u pt o2 0mL, utilizing step down PCR in which the initial
denaturation of 95uC for159 wasfollowed by 10 cycles consistingof:
95uC1 9, annealing of 5uC higher than optimal temperature listed
on primer table for 300,7 2 uC1 9300 followed by 30 cycles of 95uC
19, optimal annealing temperature as listed per each exon for 300,
72uC1 9 300 followed by an extension of 72uC for 59. Due to the
large size of exon 1, it was amplified at 95uC for 159, 35 cycles of
95uC19300,65uC30 sec,72uC2 minwithafinalextensionof729C
for 7 min. PCR products were checked on agarose gels, and then
sequenced as detailed below. Each fragment containing mutations
wasPCRamplifiedandsequencedasecondtime toconfirmthatthe
identified mutations were not due to PCR artifact.
DNA sequencing was performed using the ABI BigDye
Terminator v3.1 cycle sequencing kit and the following protocol:
10 ng (2 mL) of purified PCR amplicon, 3 mL sequencing reaction
pre-mix, 2 mL 5X sequencing buffer, 80 ng (2 mL) of primer and
11 mL of DD H20. The reaction mix was run in a PCR
thermocycler (Bio-Rad MyCycler v 1.065) and cycled as follows:
969C for 3 min followed by 25 cycles consisting of 969C for 10 s,
50 for 5 s and 609C for 4 min. Sequencing products were purified
using ABI Centri-Sep spin columns. Resuspended samples were
electrophoresed on an ABI 377 DNA sequencer. All sequences
were analyzed using BioEdit biological sequence alignment editor
(v5.0.9.1, Tom Hall, Isis Pharmaceuticals).
Sequencing of the CAG repeat: Primer labeling was set up with
25pmol of the SCA2-A (59GGGCCCCTCACCATGTCG39)
oligonucleotide primer end-labeled with c-
32P ATP (3,000 Ci/
nmol, 10 mCi/ml, 50 pmol total), 5 units (5 mL) of T4 Polynu-
cleotide Kinase (Epicentre), 5 mL of 10X Kinase Buffer and ddH20
up to 50 mL. This reaction mix was incubated at 37uC for 30 min
then heat inactivated at 70uC for 5 min.
Sequencing took place with the same cycling conditions
described above for exon 1. As template, we used 50–100fmol of
exon 1 amplicon. The sequencing protocol was followed as
described in the SequiTherm EXCEL II DNA sequencing kit.
Reaction products were resolved in a standard 6% denaturing
polyacrylamide gel, 8 M urea.
Supporting Information
Table S1 SCA2 Primer Table and predicted amplicon sizes
Found at: doi:10.1371/journal.pone.0008280.s002 (0.02 MB
XLS)
Table S2 Comprehensive SCA2 CAG Repeat Structure and
Frequency in 9 Populations
Found at: doi:10.1371/journal.pone.0008280.s001 (0.02 MB
PDF)
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